Pro-inflammatory cytokines and adipose tissue

Proceedings of the Nutrition Society

Volumn 60, Issue 3, 2001, Pages 349-356

  Coppack, S W ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adipose tissue; Cytokines; Interleukin 6; Leptin; Tumour necrosis factor

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; CYTOKINE; HYDROCORTISONE; INSULIN; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL MODEL; CONFERENCE PAPER; HYPOTHALAMUS; IMMUNOREGULATION; LIVER; MOUSE; NONHUMAN; NUTRIENT; PANCREAS;

ANIMALIA;

EID: 0034880752     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS2001110     Document Type: Conference Paper

References (83)

1. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss
2. 3-adrenergic receptor in adipose tissue
3. Control of cachexin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance
4. The role of 3′ poly(A) tail metabolism in tumor necrosis factor-alpha regulation
5. Tumor necrosis factor-α inhibits leptin production in subcutaneous and omental adipocytes from morbidly obese humans
6. Role of cytokines in inducing hyperlipidemia
7. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: Low doses stimulate hepatic triglyceride production while high doses inhibit clearance
8. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot differences and regulation by glucocorticoid
9. Cachectin/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity
10. Obesity in the new millennium
11. Processing of tumor necrosis factor-α precursor by metalloproteinases
12. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L 1 adipocytes: A possible role for interleukin 6 in cancer cachexia
13. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters
14. Effects of endotoxin and cytokines on lipid metabolism
15. Plasma concentrations of soluble TNF-alpha receptors in obese patients
16. Effects of tumour necrosis factor alpha (TNF) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture
17. The role of TNFα and TNF receptors in obesity and insulin resistance
18. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance
19. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance
20. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha
21. Uncoupling of obesity from insulin resistance through a targetted mutation in aP2, the adipocyte fatty acid binding protein
22. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance
23. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance
24. Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: Role of obesity and non-insulin dependent diabetes mellitus
25. The role of TNF-α in human adipose tissue: Prevention of weight gain at the expense of insulin resistance
26. The phosphodiesterase inhibitor IBMX suppresses TNF-α expression in human adipocyte precursor cells: A possible explanation for its adipogenic effect
27. Tumor necrosis factor-alpha mediated activation of signal transduction cascades and transcription factors in 3T3-L1 adipocytes
28. Tumor necrosis factor-alpha initiated signal transduction in 3T3-L1 adipocytes
29. Cytokines and hypothalamic-pituitary function
30. Interleukin-6 an endocrine cytokine
31. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1
32. Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells
33. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase
34. Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes
35. The endocrine function of the fat cell - Regulation by the sympathetic nervous system
36. Tumor necrosis factor is delivered to mitochondria where a tumor necrosis factor-binding protein is localised
37. Tumour necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: Implication of the p80 minor necrosis factor receptor
38. TNT and TNFR biology in health and disease
39. Interactions of noradrenalin and tumour necrosis factor α, interleukin 4 and interleukin 6 in the control of lipolysis from adipocytes around lymph nodes
40. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo
41. Subcutaneous adipose tissue secretes interleukin-6 but not tumour necrosis factor-α in vivo
42. Adipose tissue as an endocrine and paracrine organ
43. Depot-related gene expression in human subcutaneous and omental adipocytes
44. High fat diets elevate adipose tissue-derived minor necrosis factor-alpha activity
45. Adipose tissue-derived tumor necrosis factor-alpha activity is elevated in older rats
46. A metalloproteinase inhibitor blocks shedding of the IL-6 receptor and the p60 tumor necrosis factor receptor
47. Human preadipocytes display a depot-specific susceptibility to apoptosis
48. IGF-1 inhibits apoptosis induced by serum withdrawal, but potentiates TNF-α-induced apoptosis in 3T3-L1 adipocytes
49. Tumor necrosis factor α mediates apoptosis of brown adipocytes and defective brown adipocyte function in obesity
50. Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-γ2, leptin, uncoupling proteins 2 and 3, and minor necrosis factor-α gene expression in human sub-cutaneous fat by lipid infusion
51. Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM
52. Cachetin/tumor necrosis factor and interleukin-1 show different modes of combined effect on lipoprotein lipase and intracellular lipolysis
53. The pathophysiologic roles of interleukin-6 in human disease
54. Selective inhibition of synthesis of enzymes for de novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells
55. Tumor necrosis factor (TNF)-α inhibits insulin signalling through stimulation of the p55 TNF receptor and activation of sphingomyelinase
56. Thiazolidinediones block tumor necrosis factor-α-induced inhibition of insulin signalling
57. Tumor necrosis factor-alpha prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells
58. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome
59. Physiological specialisation of adipose tissue
60. Long-term changes in adipose tissue in human disease
61. Tumor necrosis factor-α induces apoptosis of human adipose cells
62. Regulation of adipose cell number in man
63. Aromatase activity and interleukin-6 production by normal and malignant breast tissues
64. Tumor necrois factor-α-induced insulin resistance in adipocytes
65. CNS regulation of thermogenesis
66. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period
67. Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia
68. Characterisation of receptor-specific TNFalpha functions in adipocyte cell lines lacking type 1 and 2 TNF receptors
69. Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro
70. Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumor necrosis factor-alpha
71. Transcriptional regression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha
72. The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production in vivo
73. Function and regulation of the beta3-adrenoceptor
74. Suppressive effect of tumor necrosis factor-α on adipogenic cell differentiation and on gene expression of hormone-sensitive lipase
75. Antidiabetic thiazolidinediones block the inhibitory effect of tumour necrosis factor-α on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells
76. Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor
77. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity
78. Protection from obesity-induced insulin resistance in mice lacking TNF-α function
79. TNF mimics the metabolic response of acute infections in healthy humans
80. Targeted disruption of the tumour necrosis factor-alpha gene: Metabolic consequences in obese and nonobese mice
81. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?
82. Negative regulation of peroxisome proliferator-activated receptor-γ gene expression contributes to the antiadipogenic effects of tumor necrosis factor-α
83. Positional cloning of the mouse obese gene and its human homologue